Collegium Pharmaceutical, Inc. to Present at 11th Annual Biotechnology Industry Organization (BIO) Investor Forum

Published: Oct 05, 2012

CUMBERLAND, R.I.--(BUSINESS WIRE)--Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain is pleased to announce that Michael Heffernan, President and CEO of Collegium, will present a corporate overview at the 11th Annual BIO Investor Forum in San Francisco, CA. The Collegium presentation will take place on Tuesday, October 9, 2012 at 8:30AM PDT in the Pacific Heights Room in the Palace Hotel in San Francisco.

Back to news